Publications

Search our bibliography using the filters on the right-hand side.

Displaying 301 through 341 of 341 publications.

Massanari M, Sacco P, Kianifard F, Maykut R, Zeldin R. Addition of omalizumab improved measures of impairment associated with moderate-severe persistent asthma. Poster presented at the American College of Chest Physicians; October 2008. Philadelphia, PA. [abstract] Chest. 134(4_MeetingAbstracts):95001.

Wertz D, Bohn R, Rodgers K, Sacco P, Pollack M, Sullivan SD. Use of administrative claims and survey data to identify asthma severity and control status and describe disease burden. Poster presented at the International Society of Pharmacoepidemiology; October 2008. Copenhagen, Denmark.

Parijs BAV, Price M, Leon F, Fehnel S. Relevance of the gastrointestinal symptom rating scale (GSRS) in patients with celiac disease. Poster presented at the American College of Gastroenterology 2008 Annual Scientific Meeting and Postgraduate Course; October 2008. Orlando, FL. [abstract] Am J Gastroenterol. 2008 Sep 1; 103(Suppl. S):S395.

Dean B, Calimlim B, Aguilar D, Sacco P, Maykut R, Tinkelman D. Sleep impairment in uncontrolled pediatric asthma. Poster presented at the American Thoracic Society; May 2008. Toronto, Canada.

Dean B, Calimlim B, Aguilar D, Sacco P, Maykut R, Tinkelman D. Impact of uncontrolled asthma on school attendance and social functioning among pediatric patients. Poster presented at the American Thoracic Society; May 2008. Toronto, Canada.

Dean B, Calimlim B, Aguilar D, Sacco P, Maykut R, Tinkelman D. Impact of uncontrolled pediatric asthma on health-related quality of life (HRQOL). Poster presented at the International Society of Pharmacoeconomics and Outcomes Research; May 2008. Toronto, Canada. [abstract] Value Health. 2008 May; 11(3):A26. doi: 10.1016/S1098-3015(10)70094-2

Dean B, Calimlim B, Aguilar D, Sacco P, Maykut R, Tinkelman D. Impact of uncontrolled pediatric asthma on child and caregiver productivity. Poster presented at the International Society of Pharmacoeconomics and Outcomes Research; May 2008. Toronto, Canada. [abstract] Value Health. 2008 May; 11(3):A279.

Wertz DA, Pollack M, Bohn R, Rodgers K, Sacco P, Sullivan SD. Impact of asthma control on quality of life. Presented at the American Academy of Allergy, Asthma, and Immunology; May 2008. Washington, DC.

Briesacher B, Sacco P, Fouayzi H, Quittner A. Tobramycin inhaled solution utilization in cystic fibrosis patients in a privately insured US population. Poster presented at the American Thoracic Society; May 2008. Toronto, Canada.

Sullivan SD, Wertz D, Pollack M, Bohn R, Sacco P. Impact of asthma control on sleep, attendance at work, normal activities and burden. Poster presented at the Academy of Managed Care Pharmacy; April 2008. San Francisco, CA.

Weiner JR, Toy EL, Sacco P, Duh MS. Costs, quality of life, and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature expert. Expert Opin Pharmacother. 2008 Apr;9(5):751-66.

Price MA, Hill CD, Williams VSL, Morlock RJ, Leeuwenkamp O, Patterson TL. Measures of functional status and quality-of-life in schizophrenia. Curr Psychiatry Rev. 2008 Feb 1;4(1):28-38.

Williams RE, Bosnic N, Sweeney CT, Duncan AW, Levine KB, Brogan M, Cook SF. Prevalence of opioid dispensings and concurrent gastrointestinal medications in Quebec. Pain Res Manag. 2008;13(5):395-400.

Cook SF, Bell T, Sweeney CT, Fehnel SE, Hollis KA. Impact on quality of life of constipation associated gi symptoms related to opioid treatment in chronic pain patients: pAC-QoL results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.

Cook SF, Bell TJ, Sweeney CT, Goss DS, Zhou X. Severity of constipation-associated gi symptoms related to opioid treatment in chronic pain patients: pac-sym questionnaire results from the opioid survey. Poster presented at the 26th Annual Scientific Meeting of the American Pain Society; May 2007.

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Shashidhar KH. Outcomes, impact and behavior associated with acute treatment of migraine. Poster presented at the 16th Migraine Trust International Symposium; November 2006. [abstract] Cephalalgia. 2006 Nov; 26(11):1358-403.

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Kori SH. The migraine assessment of current therapy (Migraine-ACT): a useful tool for detecting differences in outcomes between migraine therapies. Poster presented at the Migraine Trust International Symposium; September 2006.

Reisetter BC, Dunson DH, Kolassa EM, Schwab P. CPMM Policy Report. Effect of Medicare part D reimbursement on community pharmacy profitability. 2006. Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi.

Price MA. Standard-setting procedures report for the North Carolina checklist of academic standards (NCCLAS). 2005.

Price MA, Fiore T, Wilaby M. A study of the impact of schools attuned on special education services—phase two report. 2005.

Wilaby M, Price MA, Fiore T. A study of the impact of schools attuned on special education services— phase one report. 2004.

Fiore T, Tanner A, Price MA, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—third interim report. 2004.

Thase MF, Fava M, Hollander S, Simmons JH, Ivgy-May N, Boyle K, Gibertini M. Analysis of the effects of gepirone-ER on the Bech-6 and individual HAM-D 17-item scores. Poster presented at the 2003 42nd ACNP Annual Meeting; December 2003. San Juan, Puerto Rico.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting. Clin Ther. 2003 Jun;25(6):1872-87.

Price MA, Fiore T, Tanner A, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—updated cross project analysis report. 2003.

Sacco P, Luo R, Chang S, Sung D, Gause D. Potential benefits of rivastigmine in the nursing home population with alzheimer's disease. Poster presented at the Gerontological Society of America; December 2002. Boston, MA.

Hollis KA, Duffer A. The use of panels as an effective means of collecting patient-reported outcomes. Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.

Fiore T, Tanner A, Price MA, Bernier K, Puma M, Magliocca L. Evaluation of the state improvement grant (SIG) program—second interim report. 2002.

Findling R, Reed M, Blumer J, Boyle K, van den Heuvel M. Mirtazapine pharmacokinetics in depressed children and adolescents. Poster presented at the 2001 American Academy of Child and Adolescent Psychiatry Conference; October 2001.

Jackson LM. Home study scores and mode of recruitment as indicators of field interviewer longevity and performance on the national household survey on drug abuse. Poster presented at the 20th Annual Southern Association for Public Opinion Research Conference; October 2001.

Fiore T, Bryant K, Tanner A, Price MA, Bernier K, Puma M. Evaluation of the state improvement grant (SIG) program—first interim report. 2001.

Sacco P, Applegate P, Johnson J. A one-on-one health education program to improve medication compliance in the community-based elderly. Poster presented at the American Society of Consultant Pharmacists; January 2001. Chicago, IL.

Estrada CA, Unterborn JN, Price J, Thompson D, Gibson L. Judging the effectiveness of clinical pathways for pneumonia: the role of risk adjustment. Eff Clin Pract. 2000 Sep 1;3(5):221-8.

Price MA. Standard-setting report for the compliance official qualification examination (series 14). 2000.

Cichy E, Price MA, Warren E. Job analysis report for the general securities sales supervisor qualification examination (series 8). 2000.

Sapienza S, Sacco P, Floyd K, DiCesare J, Doan Q. Hypertension management in long-term care: opportunities for quality improvement. Poster presented at the American Medical Directors Association; 2000. San Francisco, CA.

Sacco P, Katz J, Ulanday N. Treatment of skilled nursing facility residents with Resurfix. Poster presented at the American Society of Consultant Pharmacists; January 2000. Chicago, IL.

Price MA, Fitzgerald K, Colonna A. Examination development report for the NYSE trading assistant qualification examination (series 25). 1999.

Jackson LM. Network position, power and knowledge of the political landscape: an analysis of emerging fisheries policy. Poster presented at the Southern Sociological Society annual meeting; April 1997.

Knox D, Gibson L, Zusman ME, Gallmeier C. Why college students end relationships. Coll Stud J. 1997 Jan 1;31(4):449-52.

The Multiple Sclerosis Study Group, Remavich M. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. Ann Neurol. 1990 Jun;27(6):591-605. doi: 10.1002/ana.410270603